Bristol Myers Squibb (BMY) Shares Issued (2009 - 2016)
Bristol Myers Squibb (BMY) reported Shares Issued of $37.0 million for Q4 2016, up 5.71% year-over-year from $35.0 million in Q1 2016, and up 208.33% quarter-over-quarter from $12.0 million in Q3 2016.
Bristol Myers Squibb (BMY) Shares Issued (2009 - 2016) Analysis & Trends
Bristol Myers Squibb (BMY) has 8 years of Shares Issued data on file, last reported at $37.0 million in Q4 2016.
- Shares Issued for Q4 2016 came in at $37.0 million, up 5.71% year-over-year; the trailing twelve-month figure through Dec 2016 was $181.0 million (down 31.95% YoY), and the FY2016 annual result was $181.0 million, down 31.95% from the prior year.
- Shares Issued advanced to $37.0 million in Q4 2016 per BMY's latest filing, from $12.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $270.0 million in Q1 2013 and troughed at $12.0 million in Q3 2016.
- A 5-year average of $88.1 million and a median of $63.5 million in 2012 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2012 and 2014: Shares Issued jumped 200.0% in 2012, then plunged 83.82% in 2014.
- A 5-year view of Shares Issued shows it stood at $66.0 million in 2012, then advanced by 22.73% to $81.0 million in 2013, then retreated by 27.16% to $59.0 million in 2014, then plunged by 40.68% to $35.0 million in 2015, then grew by 5.71% to $37.0 million in 2016.
- Business Quant data shows BMY's Shares Issued at $37.0 million in Q4 2016, $12.0 million in Q3 2016, and $61.0 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 37.00 Mn |
| Dec 31, 2016 | 37.00 Mn |
| Sep 30, 2016 | 12.00 Mn |
| Sep 30, 2016 | 12.00 Mn |
| Jun 30, 2016 | 61.00 Mn |
| Jun 30, 2016 | 61.00 Mn |
| Mar 31, 2016 | 71.00 Mn |
| Mar 31, 2016 | 71.00 Mn |
| Dec 31, 2015 | 35.00 Mn |
| Dec 31, 2015 | 35.00 Mn |
| Sep 30, 2015 | 30.00 Mn |
| Sep 30, 2015 | 30.00 Mn |
| Jun 30, 2015 | 27.00 Mn |
| Jun 30, 2015 | 27.00 Mn |
| Mar 31, 2015 | 174.00 Mn |
| Mar 31, 2015 | 174.00 Mn |
| Dec 31, 2014 | 59.00 Mn |
| Dec 31, 2014 | 59.00 Mn |
| Sep 30, 2014 | 29.00 Mn |
| Sep 30, 2014 | 29.00 Mn |